Viewing Study NCT01847235


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2025-12-28 @ 3:08 AM
Study NCT ID: NCT01847235
Status: COMPLETED
Last Update Posted: 2016-04-26
First Post: 2013-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Sponsor: Seoul National University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module